| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4dae7331034b6b26116b7c2f7acb115 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate |
1987-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8be42be288fd98c3341d6effa6e9ddb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b322eaec9c1a17177acf2420a8b66a30 |
| publicationDate |
1988-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-8800204-A2 |
| titleOfInvention |
Polypeptide competitor for immunoglobulin e |
| abstract |
A competitor for human Immunoglobulin E (IgE) comprises a polypeptide which has a core sequence of seventy-six amino acids which is shown, together with the corresponding DNA sequence coding therefor, in Fig. 2. This amino acid sequence, numbered 1 to 76, corresponds to amino acids 301 to 376 of the epsilon heavy chain of IgE. The polypeptide may also include additional short sequences at the beginning and/or end of the core sequence which are physiologically harmless and do not contribute to the ability of the core sequence to bind compete with native IgE for the high-affinity receptor sites on human cells. The polypeptide is indicated for the treatment of Type I hypersensitivity reactions such as hay fever. The polypeptide may be produced synthetically or by expression from Escherichia coli containing a plasmid having a DNA segment coding for the polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6610297-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7740853-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7897151-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5422258-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9412876-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8273356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9520606-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0666760-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2715304-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6919079-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5543144-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2065052-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7704506-B2 |
| priorityDate |
1986-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |